Suneel Gupta - Feb 28, 2022 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Development Officer
Signature
/s/ Donald A. Kalkofen, Attorney-in-Fact for Suneel Gupta
Stock symbol
PTGX
Transactions as of
Feb 28, 2022
Transactions value $
-$15,758
Form type
4
Date filed
3/2/2022, 07:40 PM
Previous filing
Feb 17, 2022
Next filing
Apr 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Tax liability -$15.8K -649 -0.84% $24.28 77K Feb 28, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 1,875 vested restricted stock units on February 28, 2022.